INTERNATIONAL EFFORT IN HARMONIZING COGNITIVE IMPAIRMENT RESEARCH IN SYSTEMIC LUPUS ERYTHEMATOSUS
O043 / #45 Topic: AS05 - CNS Lupus ABSTRACT CONCURRENT SESSION 07: COGNITION IMPAIRMENT IN SLE – RECENT ADVANCEMENT AND EMERGING RESEARCH 23-05-2025 1:40 PM - 2:40 PM Background/Purpose Cognitive impairment (CI) is frequently observed in systemic lupus erythematosus (SLE) and negatively affects health-related quality of life. Despite increased research in this field, there remains a lack of multicentered studies and external validation of findings between centers. This abstract summarizes the first international, multicenter meeting to discuss the harmonization of research into CI in SLE. The aims of the meeting were to identify the current challenges in this field, knowledge gaps and opportunities to harmonize research across centers. Methods Thirty-seven interdisciplinary researchers (pediatric and adult rheumatologists, psychiatrists, psychologists, physicists, engineers) from 12 centers across 6 countries were invited. Researchers were selected based on having an established publication record in the field of CI in SLE. During the meeting 2 breakout groups were created, one focused on clinical/psychological aspects and the other on neuroimaging. Key topics to discuss were prepared in advance, based on gaps in the current literature and areas that needed further understanding and consistency in research design. These included: core datasets needed for CI in SLE research, current cognitive measures used, weaknesses of these measures, differences between pediatric and adult CI, subjective vs objective CI, current neuroimaging in CI and gaps in the field. Results In terms of a core dataset there was a ‘long-list’ of factors discussed (Table 1). This was not a definitive list but a starting point for additional work required to determine priorities and core factors to consider in CI research. Instead of the American College of Rheumatology neuropsychological battery, identifying specific cognitive domains pertinent to patients with SLE was proposed. This proposed change would help overcome previous test limitations such as validation of tests in alternative languages and in a pediatric population. When considering the new domains, we also need to establish the purpose of the tool, for clinical or research. This setting would then also affect whether we need screening or in-depth measures. Measurements of both objective and subjective CI were considered important, as well as ecologically valid measures to capture cognitive performance in everyday life and measures of resilience. It was agreed that current CI measures account for some potential confounders (eg, age and sex), but other important factors are overlooked, such as social determinants of health. The use of normative data can help with some confounders but regression-based norms maybe more useful. The neuroimaging breakout group identified 10 acquisition methods in current use, with the majority collecting T1 structural, diffusion weighted imaging and resting state functional MRI. The group also identified 15 different types of software that are in use in the analysis stage (Table 2). Discussions included use of the “traveling head” methodology for multicentered studies, and the use of software algorithms in artificial intelligence to computationally harmonize some scans. Overall, in terms of harmonizing imaging research across institutes 4 areas were targeted: scanner features and location, and participant, acquisition protocol, and analytic pipeline harmonization. Table 1: A list of some factors assessed when conducting CI in SLE research Table 2: Imaging data acquisition methods and software currently used by symposium attendees Conclusions Studying CI in SLE is complex and is complicated further by its multifactorial nature and confounders. Minimizing variation by harmonizing research methods, especially clinical and imaging data acquisition and analysis across centers, is an important step to advancing knowledge of CI in the diverse population that is SLE patients. A wider international group will move forward with harmonization efforts and development of a finalized core dataset. Acknowledgment: FAPESP grant 22/00597-6.
Authors
- Diana Valdés Cabrera (ORCID: https://orcid.org/0000-0001-9374-5279)
- Shane McKie (ORCID: https://orcid.org/0000-0002-4418-8944)
- Zahi Touma (ORCID: https://orcid.org/0000-0001-5177-2076)
- Ekemini A. Ogbu (ORCID: https://orcid.org/0000-0003-2126-1587)
- Lesley Ruttan (ORCID: https://orcid.org/0000-0002-6431-5023)
- Alessandra Bortoluzzi (ORCID: https://orcid.org/0000-0003-2416-8134)
- Michelle Barraclough (ORCID: https://orcid.org/0000-0002-9698-0917)
- Rebecca Elliott
- Maria Carmela Tartaglia (ORCID: https://orcid.org/0000-0002-5944-8497)
- Letícia Rittner (ORCID: https://orcid.org/0000-0001-8182-5554)
- Elizabeth Kozora (ORCID: https://orcid.org/0000-0002-8654-5735)
- Meggan Mackay (ORCID: https://orcid.org/0000-0002-4061-3798)
- Hermine I. Brunner (ORCID: https://orcid.org/0000-0001-9478-2987)
- Erik Anderson (ORCID: https://orcid.org/0000-0003-3154-9648)
- John D. Fisk (ORCID: https://orcid.org/0000-0003-3512-8015)
- Chrisanna Dobrowolski
- John G. Hanly (ORCID: https://orcid.org/0000-0003-1029-9483)
- Christoph M. Tang (ORCID: https://orcid.org/0000-0001-8366-3245)
- Ian N Bruce (ORCID: https://orcid.org/0000-0003-3047-500X)
- Patricia Katz (ORCID: https://orcid.org/0000-0002-8146-2519)
- Sudha Raghunath (ORCID: https://orcid.org/0000-0002-3062-7328)
- Kathleen S. Bingham (ORCID: https://orcid.org/0000-0002-4539-220X)
- Mark DiFrancesco (ORCID: https://orcid.org/0000-0001-8002-0332)
- Kâmil Uludaǧ (ORCID: https://orcid.org/0000-0002-2813-5930)
- Alexandra Legge (ORCID: https://orcid.org/0000-0003-0373-4985)
- Robin Green (ORCID: https://orcid.org/0000-0001-9451-3963)
- Chris Wincup (ORCID: https://orcid.org/0000-0002-8742-8311)
- Ettore Silvagni (ORCID: https://orcid.org/0000-0001-7654-8222)
- Simone Appenzeller (ORCID: https://orcid.org/0000-0001-5075-4474)
- Susan M. Lee (ORCID: https://orcid.org/0000-0001-9016-310X)
- Ben Parker (ORCID: https://orcid.org/0000-0001-7959-6529)
- Andrea Knight (ORCID: https://orcid.org/0000-0003-4278-9049)
- Xiang He (ORCID: https://orcid.org/0000-0001-9942-0301)
- Marcello Govoni
- Alberta Hoi
Institutions
- Queen's University Belfast (GB)
- Cincinnati Children's Hospital Medical Center (US)
- Dalhousie University (CA)
- Northwell Health (US)
- University Health Network (CA)
- Feinstein Institute for Medical Research (US)
- University of California, San Francisco (US)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- University of Toronto (CA)
- University of Ferrara (IT)
- Manchester Academic Health Science Centre (GB)
- Hospital for Sick Children (CA)
- Nova Scotia Health Authority (CA)
- University of Manchester (GB)
- National Jewish Health (US)
- University of California San Diego (US)
- NIHR Oxford Musculoskeletal Biomedical Research Centre (GB)
- Manchester University NHS Foundation Trust (GB)
- Monash Health (AU)
- King's College Hospital (GB)
- NIHR Manchester Biomedical Research Centre (GB)
- University of Cincinnati (US)
- University of Colorado Denver (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-05-20
- DOI
- https://doi.org/10.3899/jrheum.2025-0390.o043
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00